Compare ADMA Biologics Inc (ADMA) vs TeraWulf Inc (WULF) Price & Performance

ADMA Biologics IncTrade

TeraWulf IncTrade

Price performance (Past 24H)

Key statistics

ADMA Biologics Inc vs TeraWulf Inc — how do they compare? ADMA Biologics Inc trades at $9.88 (market cap $2.22B), while TeraWulf Inc trades at $18.05 (market cap $8.35B). The key difference: TeraWulf Inc is far larger — about 3.8× ADMA Biologics Inc's market cap, and TeraWulf Inc is trading nearer its 52-week high, ADMA Biologics Inc nearer its low. Which is the better fit depends on your goals.

	ADMA	WULF
Market Cap	$2.22B	$8.35B
Sector	Health	Technology
52-Week High	$20.38	$28.98
52-Week Low	$7.60	$5.24
Enterprise Value	$2.29B	$10.97B

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ADMA

View details →

WULF

Neocloud stocks rise as NVIDIA-led $500B AI financing plan boosts data center buildout prospects24/7 Wall Street · 1 day agoBullish Riot Platforms shares jump 17% on $9.1B AI data center lease with Anthropic.24/7 Wall Street · 1 day agoBullish TeraWulf leads AI infrastructure stocks in 2026 with a 40.82% gain, driven by a major Anthropic lease deal.24/7 Wall Street · 1 day agoBullish View details →

About ADMA Biologics Inc

ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.

About TeraWulf Inc

TeraWulf develops, owns, and operates fully integrated digital infrastructure powered by predominantly zero-carbon energy. It utilizes a hybrid business model that combines industrial-scale Bitcoin mining with high-performance computing (HPC) and AI hosting, leveraging sustainable power sources like nuclear and hydroelectric to deliver low-cost, energy-efficient data center solutions.